18 October 2022 - Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase 3 treatment trial. ...
13 October 2022 - Telix Pharmaceuticals announces that Health Canada has approved Illuccix [kit for the preparation of gallium (Ga 68) ...
12 October 2022 - Approval based on data from the Phase 3 KEYNOTE-564 trial. ...
7 October 2022 - Today, Health Canada authorised a second bivalent COVID-19 vaccine booster. ...
6 October 2022 - Santen Canada today announced the approval of Cationorm Plus by Health Canada. ...
5 October 2022 - Today's approval was based on the pivotal Phase 3 ARASENS trial, which showed a significant overall survival ...
23 September 2022 - Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray) treats moderate to severe seasonal allergic rhinitis and associated ...
20 September 2022 - Takeda Canada is pleased to announce that Health Canada has authorized (Notice of Compliance) Livtencity (maribavir) for ...
13 September 2022 - Rymti is Lupin’s biosimilar etanercept approved for all indications of the reference product. ...
13 September 2022 - Approval is based on the Phase 3 KEYNOTE-716 trial. ...
9 September 2022 - Health Canada approves Pfizer-BioNTech COVID-19 vaccine for kids under 5. ...
7 September 2022 - Novel mechanism of action of Pluvicto binds to target PSMA positive cancer cells, delivering radiation treatment directly ...
1 September 2022 - Today, Health Canada authorised an adapted version of the Moderna Spikevax COVID-19 vaccine. ...
23 August 2022 - First and only immunotherapy-based treatment for use before surgery for non-small-cell lung cancer in Canada. ...
19 August 2022 - The 10 mcg dose can be given at least 6 months after primary series is completed. ...